HB 205 creates new pathways for substance use treatment within Utah's criminal justice system. It allows county jails to establish recovery housing pods for incarcerated individuals with substance use disorders, requiring approval by local substance abuse authorities and structured treatment programs. The bill also restricts syringe exchange programs to only distributing syringes (not other drug paraphernalia) and prohibits exchanges in public parks. Additionally, it authorizes courts to implement structured treatment programs for drug offenses and issue geographic "off-limits" orders for individuals charged with drug crimes. These changes primarily affect jails, local health authorities, and courts managing drug-related cases.
HB 402 creates a new state license specifically for emergency medical services (EMS) agencies to legally handle controlled substances (like naloxone or epinephrine) during emergencies. It requires EMS agencies to obtain this license, mandates record-keeping and storage rules, and authorizes the Division of Professional Licensing to enforce standards, deny/suspend licenses for violations, and collect fees. The bill directly affects all Utah EMS agencies currently distributing controlled substances, ensuring they operate under unified state regulations instead of relying solely on federal rules. Key provisions include requiring medical directors to issue standing orders for substance administration and setting clear procedures for license management and inspections.
HB 174 prohibits health care providers in Utah from administering cross-sex hormones or puberty blockers to minors after January 28, 2027, unless the minor was diagnosed with gender dysphoria before January 28, 2023. The bill amends Utah Code Section 58-1-603.1 to establish this ban, directly affecting minors seeking these treatments who do not meet the pre-2023 diagnosis requirement. It repeals a prior requirement for medical evidence reviews (Section 26B-1-239) and takes effect on May 6, 2026. The law applies to all minors under Utah's definition, with violations classified as unprofessional conduct for providers.
SB 222 amends Utah's "Right to Try" law to expand access to investigational drugs. It removes the requirement that patients have a terminal illness, instead allowing individuals with serious conditions that pose significant risks compared to experimental treatments and limited conventional options to qualify. The bill updates definitions to clarify "eligible illness" and expands permissible medicinal dosage forms (e.g., adding transdermal and sublingual options). This change directly affects patients seeking experimental treatments who previously faced eligibility barriers due to non-terminal diagnoses. The law takes effect May 6, 2026, with no new funding required.
SB 170 requires healthcare providers and unlicensed midwives to administer vitamin K to newborn infants within 24 hours of birth. Parents may decline this administration by signing a form acknowledging the risks of not receiving vitamin K, which must be included in the infant's medical record. The bill defines key terms like "health care provider" and "unlicensed direct-entry midwife" and applies to all newborns in Utah. This directly affects newborns, their caregivers, and healthcare providers during delivery.
HB 417 allows patients to use non-medical transportation (like family rides or public transit) for moving between healthcare facilities when their condition doesn't require ambulance transport. It requires hospitals to provide written notices explaining why ambulance isn't needed, potential insurance coverage issues, and cost details, and to help arrange the transport. Receiving facilities cannot charge for admission or readmission if the patient arrives within two hours of discharge without a medical condition change, and must hold the offered bed. The bill also protects hospitals from liability when non-medical transport is permitted under the specified conditions.
HB 414 amends Utah's definition of "public health setting" to explicitly include hospitals. This change allows dental hygienists working in hospitals to practice without requiring general supervision from a dentist (meaning a dentist doesn't need to be physically present on-site). The bill directly affects dental hygienists employed in hospital settings by expanding their scope of practice within those facilities. It does not appropriate funds or change other licensing requirements, focusing solely on clarifying where hygienists can work independently. The amendment takes effect May 6, 2026.
SB 204 requires Utah health insurers to apply the same cost-sharing rules (like copays and deductibles) for physical therapy services as they do for primary care visits. This directly affects patients seeking physical therapy and insurers, ensuring they pay no more out-of-pocket for PT than for a primary care visit. The bill amends Utah law to prohibit insurers from charging higher fees or imposing extra costs for physical therapy compared to primary care, while clarifying that physical therapists must still practice within existing scope-of-practice laws. It takes effect January 1, 2027, with no new funding required.
HB 15 amends Utah's Medicaid expansion program to address potential reductions in federal funding. It changes the automatic end date for the expansion if federal matching funds decrease, requires the Department of Health and Human Services to terminate programs that would reduce federal funds, and mandates a report to the legislature if funding drops. The bill also allows the state tax funding Medicaid expansion to end if the program concludes. These changes directly affect Utah's Medicaid beneficiaries and the state's administration of the program, focusing on maintaining federal funding alignment without new state spending.
HB 264 modifies Utah's prescription medication rules to streamline pharmacy operations. It removes the requirement for pharmacies to notify providers when substituting medications (as authorized by the prescription), allows prescription refills to remain valid for two years, and establishes new rules for standing prescriptions issued by the Department of Health and Human Services. Standing prescriptions must be limited to specific conditions, FDA-approved diagnoses, and clinically appropriate treatments. These changes primarily affect pharmacies, patients receiving refills, and healthcare providers who write prescriptions.
